Cibus Global LLC

Yahoo Finance • 21 days ago

Cibus Reports Fourth Quarter Financial Results and Provides Business Update

A major milestone on March 14th 2025 advanced the EU Trilogue discussions aimed to complete the final text of the New Genomic Techniques (NGTs) or gene editing legislation for the EU; California Rice Commission approved Cibus' field resear... Full story

Yahoo Finance • 24 days ago

Cibus Welcomes the European Union’s Progress as Legislation for New Genomic Techniques to Boost Innovation and Sustainability Moves Forward

Legislation aims to adapt EU law to reflect scientific and technological progress, enabling the products of New Genomic Techniques (NGTs), such as gene editing, to contribute to more sustainable agriculture, climate resilience, and food se... Full story

Yahoo Finance • 30 days ago

Cibus to Report Fourth Quarter 2024 Financial Results on March 20, 2025 After the Market Close and Host Conference Call

SAN DIEGO, March 11, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS), a leading agricultural biotechnology company that uses proprietary gene editing technologies to develop plant traits (or specific genetic characteristics) in seeds... Full story

Yahoo Finance • last month

Cibus’ Achieves Another Milestone for a Durable White Mold (Sclerotinia) Resistance Trait in Canola

Initial bioassay data for Cibus’ third mode of action for white mold (Sclerotinia) resistance trait in canola shows promising results in controlled environment assessment Cibus’ white mold resistance traits are expected to help preserve c... Full story

Yahoo Finance • last month

Cibus Announces Leadership Change and CEO Succession Plan

SAN DIEGO, Feb. 28, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS) (the “Company” or “Cibus”), a leading agricultural technology company that develops and licenses plant traits to seed companies for royalties, today announced key le... Full story

Yahoo Finance • 2 months ago

Totus Medicines Appoints Simon Harnest, MSc, BSc, as Chief Financial Officer

EMERYVILLE, Calif., Jan. 28, 2025 (GLOBE NEWSWIRE) -- Totus Medicines, a company revolutionizing small molecule drug discovery and development using covalent DNA-encoded libraries and AI tools, today announced the appointment of Simon Ha... Full story

Yahoo Finance • 3 months ago

Cibus to Participate in the Sidoti Micro Cap Conference

SAN DIEGO, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS) (the “Company”), a leading agricultural biotechnology company that uses proprietary gene editing technologies to develop plant traits (or specific genetic characteri... Full story

Yahoo Finance • 3 months ago

Cibus, Inc. Announces $22.6 Million Registered Direct Offering Priced Above Nasdaq’s Minimum Price in Accordance with Nasdaq Rules

SAN DIEGO, Jan. 21, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS) (the “Company” or “Cibus”), a leading agricultural biotechnology company that uses proprietary gene editing technologies to develop plant traits (or specific genetic... Full story

Yahoo Finance • last year

Cibus and Loveland Products Collaborate to Develop and Sell Rice Traits in the US

Cibus US LLC Loveland Products has also agreed to collaborate with Cibus for future product development with its Dyna-Gro rice program SAN DIEGO, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS), a leading agricultural techno... Full story

Yahoo Finance • last year

Cibus Announces New Publication: Industrial Scale Gene Editing in Brassica napus

In the peer reviewed publication, the International Journal of Plant Biology, Cibusprovides two case studies of improving oleic oil content and developing pod shatter reduction in Brassica napus (canola, winter oilseed rape) by using gene... Full story

Yahoo Finance • last year

European Parliament Releases Draft Report on the Proposal for the Regulation of Plants Obtained from New Genomic Techniques

Draft report supports the European Commission proposal to introduce a new regulation on plants obtained by certain new genomic techniques (NGTs) and their food and feedProposed regulation identifies a ‘Conventional-like’ category of NGT pr... Full story

Yahoo Finance • last year

Cibus to Report Third Quarter 2023 Financial Results on November 9, 2023 and Host Conference Call

SAN DIEGO, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS), a global leader in gene editing in agriculture and the development of productivity traits in plants, today announced that the Company will report third quarter 2023... Full story

Yahoo Finance • 2 years ago

Jim Collins to Join Cibus Board of Directors

Cibus Announces Election of New Board Member, Deepening Strategic Leadership and Experience SAN DIEGO, Sept. 18, 2023 (GLOBE NEWSWIRE) -- Cibus, Inc. (NASDAQ: CBUS), a global leader in Gene Editing in agriculture and the development of... Full story

Yahoo Finance • 2 years ago

Cibus to Present at the H.C. Wainwright 25th Annual Global Investment Conference

SAN DIEGO, Sept. 05, 2023 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS), a leading agricultural technology company that develops and licenses plant traits to seed companies, today announced that Rory Riggs, Co-Founder, Chief Executive O... Full story

Yahoo Finance • 2 years ago

Cibus Opens Dedicated, High-throughput Gene Editing Facility for Trait Production

The Facility represents the first semi-automated gene editing trait production system that provides a time-bound, predictable and reproducible breeding system for the editing of commercial plants. The Facility’s Trait MachineTM process edi... Full story

Yahoo Finance • 2 years ago

Cibus Welcomes European Commission Proposal on Regulation of Plants Obtained from New Genomic Techniques

Proposal aims to adapt EU legislation to scientific and technological progress, enabling the products of New Genomic Techniques (NGTs) to contribute to more sustainable agriculture, climate resilience, and food securityProposed regulation... Full story